- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05340478
Adjunctive Family CBT for Veterans With Anxiety (AF-CBT)
Increasing the Effectiveness of CBT for Anxiety in Veterans by Involving Family Members.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Posttraumatic stress disorder (PTSD) and anxiety disorders such as panic, generalized and social anxiety are highly prevalent among Veterans of all eras and negatively impact functioning and quality of life. Avoidance is a hallmark feature of anxiety and functions to maintain the disorder. Although cognitive behavior therapy (CBT) is effective, a significant proportion of Veterans show minimal improvement following treatment. This is often due to poor treatment adherence such as avoidance of using skills taught in CBT that require confronting distressing memories and feared situations. Avoidance behavior also can extend to caregivers and family members of Veterans, who may engage in accommodation behaviors (i.e., changing their own behaviors) to help alleviate distress experienced by their loved ones. As such, accommodation by family members undermines the effectiveness of CBT and is associated with greater symptom severity and functional impairment in persons with anxiety.
This study will examine the feasibility, acceptability, and satisfaction associated with a new intervention for family members of Veterans undergoing CBT for anxiety-based disorders. Adjunctive Family-CBT (AF-CBT) provides family members psychoeducation on anxiety and teaches skills that can be used to facilitate the recovery of Veterans who are in the process of completing treatment for anxiety. Aims of the study are to: (1) adapt and refine AF-CBT through an iterative process that will be informed by feedback from Veterans and family members; (2) examine the feasibility and acceptability/satisfaction of AF-CBT; (3) assess the validity and reliability of the Family Accommodation Scale-Anxiety adapted for Veterans and family members; and (4) examine the associations between family accommodation behavior and readjustment and anxiety in Veterans.
The proposed study involves a total of 47 Veterans and family member dyads (V/F dyad) and will be conducted in two phases. In phase 1, 12 V/F dyads will be recruited, and family members will receive AF-CBT while the Veteran undergoes iCBT for anxiety. The intervention will be delivered in three separate cohorts (approximately 4 V/F dyad in each cohort). During the 1-month assessment, information obtained from qualitative interviews will be used to refine the intervention in an iterative process with each cohort. In phase 2, 35 V/F dyads will be recruited and administered the finalized version of AF-CBT following the same treatment and assessment format. Qualitative interviews will focus on each V/F dyad's experience with the AF-CBT intervention and whether specific components of the intervention facilitated the Veteran's recovery process.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030-4211
- Michael E. DeBakey VA Medical Center, Houston, TX
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Study Population
Description
Inclusion Criteria:
- Veteran at least 18 years old;
- current diagnosis of at least one anxiety-based disorder: PTSD, PD, SAD, or GAD (based on ADIS-5);
- moderate-to-poor life enjoyment and satisfaction as indicated by a score of 47 or lower on the Q-LES-Q-SF
- BAI score of 16 (moderate anxiety) or higher;
- stable on psychotropic medication for 4 weeks before study participation; and
- has a family member willing to participate in the study
Exclusion Criteria:
- Active symptoms of mania or psychosis at baseline (based on ADIS-5);
- depression with active suicidal ideation/intent that would preclude treatment (based on ADIS-5 & BAI);
- moderate-to-severe cognitive impairment as indicated by a score below 20 on the SLUMS;
- active drug/alcohol abuse during the initial 3-months of study enrollment (otherwise Veterans with comorbid substance/alcohol dependence are study eligible); and
- undergoing concurrent transdiagnostic CBT for anxiety.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Phase 1 (Initial) - Adapt/Refine AF-CBT
Adjunctive Family - Cognitive Behavioral Therapy (AF-CBT) was adapted and refined for family members of Veterans with anxiety using an iterative process during Phase 1.
|
AF-CBT provides family members psychoeducation on anxiety and teaches skills to facilitate the recovery of Veterans in the process of completing anxiety treatment.
Other Names:
|
|
Other: Phase 2 (Final) - Pilot AF-CBT
The final version of Adjunctive Family - Cognitive Behavioral Therapy (AF-CBT) was delivered to family members of Veterans with anxiety during Phase 2.
|
AF-CBT provides family members psychoeducation on anxiety and teaches skills to facilitate the recovery of Veterans in the process of completing anxiety treatment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Treatment Evaluation Inventory
Time Frame: 1-month follow-up
|
Degree to which treatment components were found to be acceptable.
Scores range from 9-45, with higher scores reflecting greater acceptance of treatment.
|
1-month follow-up
|
|
Client Satisfaction Questionnaire
Time Frame: 1-month follow-up
|
Degree to which participant was satisfied with treatment.
Scores range from 8-32, with higher scores reflecting greater satisfaction.
|
1-month follow-up
|
|
Feasibility of Retention for AF-CBT
Time Frame: Baseline to Treatment Completion (average 4 months)
|
This outcome pertains to the feasibility of retaining participant dyads for the AF-CBT intervention across Phases 1 and 2 of the study.
The rate of retention is the percentage of dyads who complete AF-CBT by attending all sessions.
|
Baseline to Treatment Completion (average 4 months)
|
|
Feasibility of Recruitment for AF-CBT
Time Frame: Recruitment Initiation to Recruitment Completion (up to 18 Months)
|
This outcome pertains to the feasibility of recruiting participant dyads for the AF-CBT intervention across Phases 1 and 2 of the study.
The rate of recruitment is based on the number of dyads who agreed to participate out of those invited during the active recruitment period for this study.
|
Recruitment Initiation to Recruitment Completion (up to 18 Months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Anxiety Inventory
Time Frame: Baseline; 1-Month Follow-Up
|
Measure of anxiety including cognitive and somatic components of anxiety. Scores range from 0-63, with higher scores reflecting higher levels of anxiety. Note: The BAI was not collected from family members. |
Baseline; 1-Month Follow-Up
|
|
Family Accommodation Scale
Time Frame: Baseline; 1-Month Follow-Up
|
Degree to which family member engages in accommodation behaviors.
Scores range from 0-36, with higher scores reflecting greater levels of accommodation.
|
Baseline; 1-Month Follow-Up
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Ellen Teng, PhD, Michael E. DeBakey VA Medical Center, Houston, TX
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D3863-P
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Disorder
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Baylor College of MedicineActive, not recruitingGeneralized Anxiety Disorder | Panic Disorder | Panic Disorder With Agoraphobia | Separation Anxiety | Anxiety Disorder of Childhood | Panic Attacks | Social Anxiety Disorder of Childhood | Obsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceUnited States
-
Baylor College of MedicineJohns Hopkins University; University of PennsylvaniaCompletedGeneralized Anxiety Disorder | Anxiety | Autism Spectrum Disorder | Separation Anxiety | Social Anxiety Disorder of ChildhoodUnited States
-
Ibn Haldun UniversityNot yet recruitingAnxiety Disorders | Generalized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Anxiety Disorder NOSTurkey
-
University of MichiganNational Institute of Mental Health (NIMH)RecruitingGeneralized Anxiety Disorder | Anxiety | Social Anxiety Disorder | Panic DisorderUnited States
-
University of MichiganBrain & Behavior Research FoundationCompletedGeneralized Anxiety Disorder | Anxiety | Social Anxiety Disorder | Panic DisorderUnited States
-
Erasmus Medical CenterTerminatedGeneralized Anxiety Disorder | Social Anxiety Disorder | Specific Phobia | Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood, Early OnsetNetherlands
-
Psicofarma, S.A. De C.V.Recruiting
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
Clinical Trials on Adjunctive Family - Cognitive Behavioral Therapy
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderUnited States
-
Weill Medical College of Cornell UniversitySidney R. Baer, Jr. FoundationCompletedProdromal Symptoms | ARMS | APSUnited States
-
Oregon Research InstituteCompleted
-
University of FloridaNational Institutes of Health (NIH)Completed
-
Mae Lynn Reyes-Rodriguez, PhDNational Institute of Mental Health (NIMH); University of North Carolina, Chapel... and other collaboratorsCompletedBulimia Nervosa | Binge Eating Disorder | Eating Disorder Not Otherwise SpecifiedUnited States
-
Baylor College of MedicineRecruitingPanic Disorder | Separation Anxiety Disorder | Anxiety Disorder of Childhood or Adolescence | Obsessive Compulsive Disorder (OCD) | Panic Attacks | Social Anxiety Disorder of Childhood | Phobia, Specific | Generalized Anxiety Disorder (GAD) | Panic Disorder (With or Without Agoraphobia)United States
-
The Miriam HospitalUnknownEating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia Nervosa Restricting TypeUnited States
-
Stanford UniversityUniversity of ChicagoCompleted
-
University of AmsterdamNetherlands Organisation for Scientific ResearchCompleted
-
Children's Hospital Medical Center, CincinnatiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Withdrawn